Literature DB >> 80425

Rabbit latent group a allotypes: characterization and relationship to nominal group a allotypic specificities.

M Mudgett-Hunter, M L Yarmush, B A Fraser, T J Kindt.   

Abstract

Latent group a allotypes were detected with a sensitive radioimmune inhibition assay. Sera, IgG preparations, and antibody fractions containing these allotypes inhibited the binding of insolubilized allotypic antisera to various radiolabeled antigens including IgG pools, homogeneous antibodies, and, in the case of a3, a VH fragment from a3/b4 IgG. Several different group a antiallotypic sera were used in the assays and all gave similar results. Comparison of inhibition curves for nominal and latent allotypes indicated that the full spectrum of allotypic subspecificities may be expressed in latent allotypes. Hemagglutination studies carried out with five sera containing high levels of latent allotypes confirmed the results obtained with the radioimmunoassay and indicated that inhibition values did not, at least in four of the five samples studied, reflect the presence of antiallotype antibodies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80425

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Rabbit latent allotypes: current status and future directions.

Authors:  K H Roux
Journal:  Surv Immunol Res       Date:  1983

2.  Rabbit heavy chain haplotypes--allotypic determinants expressed by VH-CH recombinants.

Authors:  R G Mage; S Dray; A Gilman-Sachs; C Hamers-Casterman; R Hamers; W C Hanly; T J Kindt; K L Knight; W J Mandy; J Naessens
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

3.  Role of immune recognition in latent allotype induction and clearance. Evidence for an allotypic network.

Authors:  M L Yarmush; J A Sogn; P D Kern; T J Kindt
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

4.  Radioimmune analysis of an unexpected mouse allotype.

Authors:  C L DeWitt; M J Bosma
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.